MAPT and Alzheimer disease: The multimodal study of tau pathology, in relation to glucose metabolism ([18F]FDG) and amyloid-beta deposition ([11C]PIB), provides a suitable design for exploring the regional and temporal evolution of the underlying pathologies in AD.